GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AIxCrypto Holdings, Inc. (AIXC) | 8/7/2026 5:36:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $7,402,799 | EPS -$0.21 | ||
| AIxCrypto Holdings, Inc. (AIXC) | 8/7/2026 5:22:18 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $7,402,799 | EPS -$0.21 | Export Earnings Model | ||
| AIxCrypto Holdings, Inc. (AIXC) | 7/16/2026 6:16:09 AM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Assets $31,279,846 | EPS -$8.11 | ||
| AIxCrypto Holdings, Inc. (AIXC) | 5/12/2026 6:05:49 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $23,901,682 | EPS -$0.79 | Export Earnings Model | ||
| AIxCrypto Holdings, Inc. (AIXC) | 5/11/2026 4:43:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $23,901,682 | EPS -$0.79 | ||
| AIxCrypto Holdings, Inc. (AIXC) | 3/30/2026 6:32:17 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $31,279,846 | EPS -$8.11 | ||
| AIxCrypto Holdings, Inc. (AIXC) | 3/27/2026 5:03:08 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $31,279,846 | EPS -$3.76 | Export Earnings Model | ||
| AIxCrypto Holdings, Inc. (AIXC) | 12/15/2025 10:13:00 AM | View | Proxy | SEC | Y 2024 | ||||||
| Qualigen Therapeutics, Inc. (AIXC) | 11/14/2025 5:22:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $43,470,364 | EPS -$4.68 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 10/20/2025 5:37:35 PM | View | Proxy | SEC | Y 2024 | ||||||
| Qualigen Therapeutics, Inc. (AIXC) | 8/14/2025 5:34:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $3,962,673 | EPS -$1.00 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 7/21/2025 5:31:46 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $2,847,538 | EPS -$1.82 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 6/30/2025 5:33:21 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $4,686,519 | EPS -$17.55 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 11/14/2024 4:41:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $2,312,994 | EPS -$4.70 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 9/10/2024 6:02:20 AM | View | Proxy | SEC | Y 2023 | ||||||
| Qualigen Therapeutics, Inc. (AIXC) | 8/14/2024 4:20:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $534,410 | EPS -$0.21 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 7/2/2024 3:48:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $1,003,211 | EPS -$0.35 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 4/8/2024 6:18:19 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $2,033,248 | EPS -$2.46 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 11/14/2023 8:47:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $4,316,060 | EPS -$0.64 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/15/2023 10:05:40 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $1,627,031 +13.7% | Assets $13,149,572 | EPS -$0.69 | Export Earnings Model | |
| Qualigen Therapeutics, Inc. (AIXC) | 8/14/2023 4:29:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $1,627,031 +13.7% | Assets $13,149,572 | EPS -$0.69 | |
| Qualigen Therapeutics, Inc. (AIXC) | 7/7/2023 5:18:28 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $4,983,556 -11.9% | Assets $19,083,491 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 6/2/2023 4:06:30 PM | View | Proxy | SEC | Y 2022 | ||||||
| Qualigen Therapeutics, Inc. (AIXC) | 5/16/2023 8:02:40 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Rev $1,607,170 +122.6% | Assets $15,914,135 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 5/15/2023 4:24:05 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $1,607,170 +122.6% | Assets $15,914,135 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 5/2/2023 4:44:45 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $4,983,556 -11.9% | Assets $19,083,491 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 5/2/2023 4:32:11 PM | View | Financials | Earnings | WIRE | Y 2022 | Rev $1,389,928 -43.4% | Assets $19,083,491 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 11/15/2022 7:32:03 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Rev $1,441,065 +24.8% | Assets $22,958,832 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 11/14/2022 5:09:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $1,441,065 +72.0% | Assets $22,958,832 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 11/14/2022 5:09:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $1,441,065 +24.8% | Assets $22,958,832 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/16/2022 6:22:19 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $1,430,534 +28.0% | Assets $26,348,851 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/15/2022 4:36:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $1,430,534 +58.2% | Assets $26,348,851 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/15/2022 4:36:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $1,430,534 +28.0% | Assets $26,348,851 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 7/13/2022 6:16:32 AM | View | Proxy | SEC | Y 2021 | ||||||
| Qualigen Therapeutics, Inc. (AIXC) | 5/13/2022 6:31:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $722,029 -62.0% | Assets $18,708,453 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 5/13/2022 6:12:39 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $722,029 -62.0% | Assets $18,708,453 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 4/29/2022 5:19:55 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Rev: $5,653,725 +31.3% | Assets $22,835,705 | EPS -$0.61 | |
| Qualigen Therapeutics, Inc. (AIXC) | 4/1/2022 8:01:10 AM | View | Financials | Earnings | WIRE | Y 2021 | Rev $2,455,189 | Assets $22,835,705 | EPS -$0.61 | Export Earnings Model | |
| Qualigen Therapeutics, Inc. (AIXC) | 3/31/2022 4:25:57 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $5,653,725 +31.3% | Assets $22,835,705 | EPS -$0.61 | |
| Qualigen Therapeutics, Inc. (AIXC) | 11/15/2021 9:10:45 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | ||||
| Qualigen Therapeutics, Inc. (AIXC) | 11/15/2021 9:03:11 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $1,155,065 | Assets $16,404,564 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/17/2021 8:31:40 AM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $1,117,935 | Assets $19,888,930 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/16/2021 4:35:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | ||||
| Qualigen Therapeutics, Inc. (AIXC) | 5/14/2021 1:13:24 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $1,899,496 +30.4% | Assets $25,735,624 | ||
| Qualigen Therapeutics, Inc. (AIXC) | 4/29/2021 3:17:37 PM | View | Proxy | SEC | Y 2020 | ||||||
| Qualigen Therapeutics, Inc. (AIXC) | 3/31/2021 4:45:07 PM | Micro | View | Financials | 10-KT | SEC | Y 2020 ending: 12/31/2020 | ||||
| Qualigen Therapeutics, Inc. (AIXC) | 11/13/2020 9:03:58 AM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $1,117,935 | Assets $19,888,930 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 11/12/2020 5:22:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 9/30/2020 | ||||
| Qualigen Therapeutics, Inc. (AIXC) | 8/14/2020 5:34:24 PM | View | Financials | Earnings | WIRE | 1Q 2021 | Rev $1,899,496 +30.4% | Assets $25,735,624 | Export Earnings Model | ||
| Qualigen Therapeutics, Inc. (AIXC) | 8/14/2020 4:34:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 6/30/2020 | Rev: $1,899,496 +30.4% | Assets $25,735,624 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/1/2020 5:45:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $1,456,755 | Assets $3,720,014 | EPS -$0.16 | |
| RITTER PHARMACEUTICALS INC (AIXC) | 5/1/2020 5:29:49 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $1,456,755 | Assets $3,720,014 | EPS -$0.16 | Export Earnings Model | |
| RITTER PHARMACEUTICALS INC (AIXC) | 3/31/2020 5:31:48 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 3/31/2020 5:30:52 PM | View | Financials | Earnings | SEC | Y 2019 | Export Earnings Model | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/14/2019 7:06:13 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $2,899,965 | EPS -$0.06 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/14/2019 6:01:36 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $2,899,965 | EPS -$0.06 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/14/2019 5:48:55 PM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $5,014,190 | EPS -$0.11 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/14/2019 5:25:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $5,014,190 | EPS -$0.11 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/15/2019 4:35:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $8,961,016 | EPS -$0.58 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/15/2019 4:11:00 PM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $8,961,016 | EPS -$0.58 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 4/26/2019 6:21:46 AM | View | Proxy | SEC | Y 2018 | ||||||
| RITTER PHARMACEUTICALS INC (AIXC) | 4/1/2019 6:34:31 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 3/29/2019 9:26:05 AM | View | Financials | Earnings | SEC | Y 2018 | Export Earnings Model | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/9/2018 9:08:16 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $12,994,310 | EPS -$0.86 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/9/2018 7:11:24 AM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $12,994,310 | EPS -$0.86 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/15/2018 6:34:08 AM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $16,826,405 | EPS -$0.71 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/14/2018 4:55:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $16,826,405 | EPS -$0.71 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/15/2018 5:55:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $19,126,964 | EPS -$0.41 | ||
| Ritter Pharmaceuticals Inc (AIXC) | 5/15/2018 4:10:21 PM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $19,126,964 | EPS -$0.41 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/15/2018 6:17:26 AM | View | Proxy | SEC | Y 2017 | ||||||
| RITTER PHARMACEUTICALS INC (AIXC) | 3/19/2018 6:46:02 AM | View | Financials | Earnings | SEC | Y 2017 | Export Earnings Model | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 3/19/2018 6:45:31 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 12/1/2017 6:16:49 AM | View | Proxy | SEC | Y 2016 | ||||||
| RITTER PHARMACEUTICALS INC (AIXC) | 10/31/2017 6:26:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $4,160,189 | EPS -$0.14 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/9/2017 6:02:21 AM | View | Proxy | SEC | Y 2016 | ||||||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/7/2017 6:24:49 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $5,792,948 | EPS -$1.41 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/9/2017 7:26:51 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $5,274,597 | EPS -$1.44 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 4/21/2017 6:15:45 AM | View | Proxy | SEC | Y 2016 | ||||||
| RITTER PHARMACEUTICALS INC (AIXC) | 2/27/2017 1:50:00 PM | View | Financials | Earnings | SEC | Y 2016 | Export Earnings Model | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 2/27/2017 6:14:05 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/7/2016 8:34:08 AM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $8,733,539 | EPS -$0.41 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/7/2016 6:13:06 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $8,733,539 | EPS -$0.41 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 10/25/2016 5:21:35 PM | View | Financials | Earnings (Prelim) | SEC | 3Q 2016 | Export Earnings Model | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/8/2016 6:22:24 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $10,874,042 | EPS -$0.48 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/9/2016 7:30:43 AM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $14,269,738 | EPS -$0.36 | Export Earnings Model | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 5/9/2016 6:33:07 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $14,269,738 | EPS -$0.36 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 4/21/2016 6:16:22 AM | View | Proxy | SEC | Y 2015 | ||||||
| RITTER PHARMACEUTICALS INC (AIXC) | 3/21/2016 6:29:35 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | ||||
| RITTER PHARMACEUTICALS INC (AIXC) | 11/10/2015 3:38:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $16,577,688 | EPS -$0.40 | ||
| RITTER PHARMACEUTICALS INC (AIXC) | 8/12/2015 4:11:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $19,715,970 | EPS -$4.18 |